Literature DB >> 36097592

Correlation Analysis of Early Renal Injury in Elderly Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease.

Dong Zhang1.   

Abstract

Objective: To investigate the correlation between serum cystatin C (Cys-C) and beta-2 (β2) microglobulin (β2-MG) levels and renal injury in elderly patients with acute exacerbations of chronic obstructive pulmonary disease (AECOPD) with a view to detecting renal injury in its early stages.
Methods: A total of 106 patients with AECOPD were enrolled and divided into three groups according to their oxygen partial pressure (PO2) levels: severe hypoxia group, moderate hypoxia group, and mild hypoxia group. Another 60 healthy subjects were selected as the control group. General clinical data were collected from all the study subjects, along with measurements of arterial blood gas, Cys-C, β2-MG, serum creatinine (Scr), urea nitrogen (BUN), partial pressure of carbon dioxide (PCO2), and high-sensitivity C-reactive protein (hs-CRP).
Results: The levels of hs-CRP, Cys-C, β2-MG, Scr, and BUN were highest in the severe hypoxia group, followed by the moderate hypoxia group, then the mild hypoxia group, and lowest in the control group. The differences between the groups were statistically significant for these indicators (P < 0.05). Apart from in the cases of Scr and BUN, there were no statistically significant differences between the mild group and the control group (P > 0.05). The levels of Cys-C and β2-MG were positively correlated with the levels of hs-CRP, PCO2, Scr, and BUN and negatively correlated with PO2 levels. hs-CRP and PO2 were high-risk factors influencing Cys-C levels, and β2-MG was a risk factor influencing Cys-C levels. The level of PO2 was a high-risk factor influencing β2-MG levels, and PCO2 and Cys-C were risk factors influencing β2-MG levels.
Conclusion: Renal injury was found to be present in patients with AECOPD and worsened with increasing degrees of hypoxia. Hypoxia and inflammation might be risk factors for renal injury in patients with AECOPD, Cys-C and β2-MG could be sensitive indicators for the early detection of renal injury.
© 2022 Zhang.

Entities:  

Keywords:  acute exacerbations of chronic obstructive pulmonary disease; cystatin C; early renal injury; β2 microglobulin

Mesh:

Substances:

Year:  2022        PMID: 36097592      PMCID: PMC9464007          DOI: 10.2147/COPD.S377847

Source DB:  PubMed          Journal:  Int J Chron Obstruct Pulmon Dis        ISSN: 1176-9106


  11 in total

1.  Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2019 Report: Future Challenges.

Authors:  José Luis López-Campos; Juan José Soler-Cataluña; Marc Miravitlles
Journal:  Arch Bronconeumol (Engl Ed)       Date:  2019-07-15       Impact factor: 4.872

2.  Our Experience on Silicone Y-Stent for Severe COPD Complicated With Expiratory Central Airway Collapse.

Authors:  Mehmet A Ozgul; Erdogan Cetinkaya; Mustafa Cortuk; Sinem Iliaz; Elif Tanriverdi; Sule Gul; Guler Ozgul; Hilal Onaran; Kenan Abbasli; Huseyin E Dincer
Journal:  J Bronchology Interv Pulmonol       Date:  2017-04

3.  Serum cystatin C as an earlier predictor of acute kidney injury than serum creatinine in preterm neonates with respiratory distress syndrome.

Authors:  Noha Ahmed Abdelaal; Sherein Abdelhamid Shalaby; Abdelmoneim Kassem Khashana; Amina Mohamed Abdelwahab
Journal:  Saudi J Kidney Dis Transpl       Date:  2017 Sep-Oct

4.  The interactions between cigarette smoking and reduced lung function on systemic inflammation.

Authors:  Wen Qi Gan; S F Paul Man; Don D Sin
Journal:  Chest       Date:  2005-02       Impact factor: 9.410

5.  Chronic renal failure: a neglected comorbidity of COPD.

Authors:  Raffaele Antonelli Incalzi; Andrea Corsonello; Claudio Pedone; Salvatore Battaglia; Giuseppe Paglino; Vincenzo Bellia
Journal:  Chest       Date:  2009-11-10       Impact factor: 9.410

Review 6.  Systemic manifestations and comorbidities of COPD.

Authors:  P J Barnes; B R Celli
Journal:  Eur Respir J       Date:  2009-05       Impact factor: 16.671

7.  End-of-Life Spending and Healthcare Utilization Among Older Adults with Chronic Obstructive Pulmonary Disease.

Authors:  Anand S Iyer; Christine A Goodrich; Mark T Dransfield; Shama S Alam; Cynthia J Brown; C Seth Landefeld; Marie A Bakitas; Jeremiah R Brown
Journal:  Am J Med       Date:  2019-12-27       Impact factor: 4.965

8.  Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary.

Authors:  Claus F Vogelmeier; Gerard J Criner; Fernando J Martinez; Antonio Anzueto; Peter J Barnes; Jean Bourbeau; Bartolome R Celli; Rongchang Chen; Marc Decramer; Leonardo M Fabbri; Peter Frith; David M G Halpin; M Victorina López Varela; Masaharu Nishimura; Nicolas Roche; Roberto Rodriguez-Roisin; Don D Sin; Dave Singh; Robert Stockley; Jørgen Vestbo; Jadwiga A Wedzicha; Alvar Agustí
Journal:  Am J Respir Crit Care Med       Date:  2017-03-01       Impact factor: 21.405

9.  Metabolomic fingerprinting and systemic inflammatory profiling of asthma COPD overlap (ACO).

Authors:  Nilanjana Ghosh; Priyanka Choudhury; Sandeep Rai Kaushik; Rakesh Arya; Ranjan Nanda; Parthasarathi Bhattacharyya; Sushmita Roychowdhury; Rintu Banerjee; Koel Chaudhury
Journal:  Respir Res       Date:  2020-05-24

10.  Target renal damage: the microvascular associations of increased aortic stiffness in patients with COPD.

Authors:  Michelle John; Samia Hussain; Andrew Prayle; Rebecca Simms; John R Cockcroft; Charlotte E Bolton
Journal:  Respir Res       Date:  2013-03-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.